Direct Measurement of ATP7B Peptides Is Highly Effective in the Diagnosis of Wilson Disease
Collins, Christopher J.; Yi, Fan; Dayuha, Remwilyn; Duong, Phi; Horslen, Simon; Camarata, Michelle; Coskun, Ayse K.; Houwen, Roderick H.J.; Pop, Tudor L.; Zoller, Heinz; Yoo, Han wook; Jung, Sung Won; Weiss, Karl H.; Schilsky, Michael L.; Ferenci, Peter; Hahn, Si Houn
(2021) Gastroenterology, volume 160, issue 7, pp. 2367 - 2382.e1
(Article)
Abstract
Background & Aims: Both existing clinical criteria and genetic testing have significant limitations for the diagnosis of Wilson disease (WD), often creating ambiguities in patient identification and leading to delayed diagnosis and ineffective management. ATP7B protein concentration, indicated by direct measurement of surrogate peptides from patient dried blood spot samples,
... read more
could provide primary evidence of WD. ATP7B concentrations were measured in patient samples from diverse backgrounds, diagnostic potential is determined, and results are compared with biochemical and genetic results from individual patients. Methods: Two hundred and sixty-four samples from biorepositories at 3 international and 2 domestic academic centers and 150 normal controls were obtained after Institutional Review Board approval. Genetically or clinically confirmed WD patients with a Leipzig score >3 and obligate heterozygote (carriers) from affected family members were included. ATP7B peptide measurements were made by immunoaffinity enrichment mass spectrometry. Results: Two ATP7B peptides were used to measure ATP7B protein concentration. Receiver operating characteristics curve analysis generates an area under the curve of 0.98. ATP7B peptide analysis of the sequence ATP7B 887 was found to have a sensitivity of 91.2%, specificity of 98.1%, positive predictive value of 98.0%, and a negative predictive value of 91.5%. In patients with normal ceruloplasmin concentrations (>20 mg/dL), 14 of 16 (87.5%) were ATP7B-deficient. In patients without clear genetic results, 94% were ATP7B-deficient. Conclusions: Quantification of ATP7B peptide effectively identified WD patients in 92.1% of presented cases and reduced ambiguities resulting from ceruloplasmin and genetic analysis. Clarity is brought to patients with ambiguous genetic results, significantly aiding in noninvasive diagnosis. A proposed diagnostic score and algorithm incorporating ATP7B peptide concentrations can be rapidly diagnostic and supplemental to current Leipzig scoring systems.
show less
Download/Full Text
Keywords: Adolescent, Adult, Aged, Case-Control Studies, Ceruloplasmin/analysis, Child, Child, Preschool, Copper-Transporting ATPases/blood, Female, Genetic Testing/methods, Hepatolenticular Degeneration/diagnosis, Heterozygote, Humans, Infant, Male, Mass Spectrometry, Middle Aged, Peptides/blood, Predictive Value of Tests, ROC Curve, Sensitivity and Specificity, Young Adult, Journal Article, Research Support, N.I.H., Extramural
ISSN: 0016-5085
Publisher: W.B. Saunders Ltd
Note: Funding Information: Funding This study was supported by the grants from NIH - R21HD097558 , and R01HD098180 and Wilson Disease Association . Funding Information: Funding This study was supported by the grants from NIH-R21HD097558, and R01HD098180 and Wilson Disease Association. Publisher Copyright: © 2021 The Authors
(Peer reviewed)